Jacob Leach S.'s most recent trade in Dexcom Inc was a trade of 14,076 Common Stock done at an average price of $70.4 . Disclosure was reported to the exchange on March 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| DexCom | Jacob Leach S. | EVP, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 70.38 per share. | 12 Mar 2025 | 14,076 | 313,497 (0%) | 0% | 70.4 | 990,670 | Common Stock |
| DexCom | Jacob Leach S. | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2025 | 35,906 | 304,775 (0%) | 0% | 0 | Common Stock | |
| DexCom | Jacob Leach S. | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2025 | 22,798 | 327,573 (0%) | 0% | 0 | Common Stock | |
| DexCom | Jacob Leach S. | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 7,107 | 271,278 (0%) | 0% | 0 | Common Stock | |
| DexCom | Jacob Leach S. | EVP, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 86.91 per share. | 28 Jan 2025 | 2,634 | 268,644 (0%) | 0% | 86.9 | 228,932 | Common Stock |